# Comparison of Fenofibric Acid Bioavailability From ABT-335 Capsules

> **NCT00839293** · PHASE1 · COMPLETED · sponsor: **Abbott** · enrollment: 32 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** ABT-335

## Key facts

- **NCT ID:** NCT00839293
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2009-03
- **Final completion:** —
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2010-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00839293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00839293, "Comparison of Fenofibric Acid Bioavailability From ABT-335 Capsules". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT00839293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*